Optimizing Care and Reducing Disparities for Children and Adults With Moderate to Severe Atopic Dermatitis: Practical Strategies for Inner-City Communities

Regional experts will present the most up to date management strategies, discuss patient cases from their own practices, and engage attendees to provide their perspectives on managing common clinical challenges in atopic dermatitis care within inner-city communities.

Share

Program Content

Activities

  • MM on Disparities in AD
    Medical Minute 1: Optimizing Care and Reducing Disparities for Children and Adults With Moderate to Severe Atopic Dermatitis: Practical Strategies for Inner-City Communities
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 09, 2023

    Expires: March 08, 2024

  • MM Case 1 on Disparities in AD
    Medical Minute 2: Optimizing Care and Reducing Disparities for Children and Adults With Moderate to Severe Atopic Dermatitis: Practical Strategies for Inner-City Communities – Case 1
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 10, 2023

    Expires: March 09, 2024

  • MM Case 2 on Disparities in AD
    Medical Minute 3: Optimizing Care and Reducing Disparities for Children and Adults With Moderate to Severe Atopic Dermatitis: Practical Strategies for Inner-City Communities – Case 2
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 10, 2023

    Expires: March 09, 2024

Faculty

cover img faculity

Leighanne McGill, PA-C

Dermatology Physician Assistant
Diplomate Fellow
Society of Dermatology Physician Assistants
New York, New York

cover img faculity

Heather Woolery-Lloyd, MD

Director, Skin of Color Division
Dr. Philip Frost Department of Dermatology and Cutaneous Surgery
University of Miami Miller School of Medicine
Miami, Florida

Provided by

ProCE Banner
ProCE Banner

Provided by Partners for Advancing Clinical Education (PACE) and Clinical Care Options, LLC (CCO).

Supporters

Supported by educational grants from

Regeneron Pharmaceuticals

Sanofi